medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2012, Número 6

<< Anterior Siguiente >>

Ann Hepatol 2012; 11 (6)


Alcohol effects on liver diseases: good or bad buddy?

Barbero-Becerra VJ, López-Velázquez JA, Sánchez-Valle V, Uribe M, Méndez-Sánchez N

Idioma: Ingles.
Referencias bibliográficas: 40
Paginas: 944-948
Archivo PDF: 112.95 Kb.


FRAGMENTO

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Seth D, Haber PS, Syn WK, Diehl AM, Day CP. Pathogenesis of alcohol-induced liver disease: classical concepts and recent advances. J Gastroenterol Hepatol 2011; 26: 1089-105.

  2. Oshita M, Hayashi N, Kasahaela N, Hagiwaeu H, Mita E, Naito M, Katayama K, et al. Increased Serum Hepatitis C Virus RNA Levels Among Alcoholic Patients with Chronic Hepatitis C. Hepatology 1994; 20: 1115-20.

  3. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol- use disorders. Lancet 2009; 373: 2223-33.

  4. Tome S, Lucey M. Review article: current management of alcoholic liver disease. Aliment. Pharmacol Ther 2004; 19: 707-14.

  5. Dunn W, Sanyal AJ, Brunt EM, Unalp-Arida A, Donohue M, McCullough AJ, Schwimmer JB. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). J Hepatol 2012; 57: 384-39.

  6. Pessione F, Degos FO, Marcellin P, Duchatelle V, Njapoum C, Martinot PM, Degott C, et al. Effect of Alcohol Consumption on Serum Hepatitis C Virus RNA and Histological Lesions in Chronic Hepatitis C. Hepatology 1998;27:1717-22.

  7. Cromie SL, Jenkins PJ, Bowden DS, Dudley FJ. Chronic hepatitis C: effect of alcohol on hepatitic activity and viral titre. J Hepatol 1996; 25: 821-6.

  8. Balasubramanian S, Kowdley K. Effect of Alcohol on Viral Hepatitis and Other Forms of Liver Dysfunction. Clin Liver Dis 2005; 9: 83-101.

  9. Nomura H, Hayashi J, Kajiyama W, Kashiwagi S. Alcohol consumption and seroconversion from hepatitis B e antigen in the Okinawa Japanese. Fukuoka Igaku Zasshi 1996; 87: 237-41.

  10. Wiley TE, McCarthy M, Breidi L, McCarthy M, Layden TJ. Impact of Alcohol on the Histological and Clinical Progression of Hepatitis C Infection. Hepatology 1998; 28: 805-09.

  11. Mello T, Ceni E, Surrenti C, Galli A. Alcohol induced hepatic fibrosis: role of acetaldehyde. Mol Aspects Med 2008; 29: 17-21.

  12. Niemela O. Distribution of ethanol-induced protein adducts in vivo: relationship to tissue injury. Free Radic Biol Med 2001; 31: 1533-8.

  13. Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol 2001; 35: 297-306.

  14. Mato JM, Camara J, Fernandez de Paz J, Caballería L, Coll S, Caballero A, García-Buey L, et al. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol 1999: 30: 1081-9.

  15. Kendrick SF, O’Boyle G, Mann J, Zeybel M, Palmer J, Jones DE, Day CP. Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis. Hepatology 2010; 51: 1988-97.

  16. Alisi A, Ghidinelli M, Zerbini A, Missale G, Balsano C. Hepatitis C virus and alcohol: same mitotic targets but different signaling pathways. J Hepatol 2011; 54: 956-63.

  17. Mas VR, Fassnacht R, Archer KJ, Maluf D. Molecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis. Mol Med 2010; 16: 287-97.

  18. Dey A, Cederbaum AI. Alcohol and oxidative liver injury. Hepatology 2006; 43: S63-S74.

  19. Suzuki A, Angulo P, St. Sauver J, Muto A, Okada T, Lindor K. Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia. Am J Gastroenterol 2007; 102: 1912-9.

  20. Dunn W, Xu R, Schwimmer JB. Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease. Hepatology 2008; 47: 1947–54.

  21. Anand BS, Thornby J. Alcohol has no effect on hepatitis C virus replication: a meta-analysis. Gut 2005; 54: 1468-72.

  22. Ekstedt M, Franzén LE, Holmqvist M, Bendtsen P, Mathiesen UL, Bodemar G, Kechagias S. Alcohol consumption is associated with progression of hepatic fibrosis in non-alsulin coholic fatty liver disease. Scand J Gastroenterol 2009; 44: 366-74.

  23. Westin J, Lagging LM, Spak F, Aires N, Svensson E, Lindh M, Dhillon AP, et al. Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J Viral Hepatitis 2002; 9: 235-41.

  24. Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, Saveria L, et al. Drinking habits as cofactors of risk for alcohol induced liver damage. Gut 1997; 41: 845-50.

  25. Gronbaek M, Jensen MK, Johansen D, Sorensen T, Becker U. Intake of Beer, Wine and Spirits and Risk of Heavy Drinking and Alcoholic Cirrhosis. Biol Res 2004; 37: 195-200.

  26. Chalasani N, Gorski JC, Asghar MS, Asghar A, Foresman B, Hall SD, Crabb DW. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology 2003; 37: 544-50.

  27. Ruhl CE, Everhart JE. Joint Effects of Body Weight and Alcohol on Elevated Serum Alanine Aminotransferase in the United States Population. Clinical Gastroenterology and Hepatology 2005; 3: 1260-8.

  28. Elmadhun NY, Lassaletta AD, Chu LM. Vodka and wine consumption in a swine model of metabolic syndrome alters insulin signaling pathways in the liver and skeletal muscle. Surgery 2012; 152: 414-22.

  29. Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, Taylor PR. Effects of moderate alcohol intake on fasting insulin and glucose concentration and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA 2002; 287: 2559-62.

  30. Bonnet F, Disse E, Laville M, Mari A, Hojlund K, Anderwald CH, Piatti P, et al. Moderate alcohol consumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy women. Diabetologia 2012.

  31. Wannamethee SG, Camargo CA, Manson JE, Willet WC, Rimm EB. Al cohol drinking patterns and risk of type 2 diabetes mellitus among younger women. Arch Intern Med 2003; 163: 1329-36.

  32. Howard AA, Arnsten JH, Gourevitch MN. Effect of alcohol consumption on diabetes mellitus: a systematic review. Ann Intern Med 2004; 140: 211-9.

  33. Ghouri N, Preiss D, Sattar N. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology 2010; 52: 1156-61.

  34. Liangpunsakul S, Chalasani N. What Should We Recommend to Our Patients with NAFLD Regarding Alcohol Use? Am J Gastroenterol 2012; 107: 976-8.

  35. Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med 2006; 166: 2437-45.

  36. Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, Heath CW Jr, Doll R. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med 1997; 337: 1705-14.

  37. O’Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Hepatology 2010; 51: 307-28.

  38. Tsukamoto H, Machida K, Dynnyk A, Mkrtchyan H. “Second hit” models of alcoholic liver disease. Semin Liver Dis 2009; 29: 178-87.

  39. De Alwis WNM, Day CP. Genetics of alcoholic liver disease and nonalcoholic fatty liver disease. Semin Liver Dis 2007; 27: 44-54.

  40. Gao B, Bataller R. Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets. Gastroenterology 2011; 141: 1572-85.




2020     |     www.medigraphic.com